Contineum Therapeutics, Inc. Class A Common Stock (CTNM)
USD 5.73
(-6.53%)
USD 5.73
(-6.53%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 177.66 Million USD | 33.82% |
| 2022 | 132.76 Million USD | 47484.95% |
| 2021 | 279 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 176.94 Million USD | -0.41% |
| 2024 Q2 | -76.63 Million USD | -143.31% |
| 2023 Q4 | 177.66 Million USD | 1183.33% |
| 2023 Q3 | -16.4 Million USD | 0.0% |
| 2023 FY | 177.66 Million USD | 33.82% |
| 2023 Q1 | 47.23 Million USD | -64.42% |
| 2022 Q4 | 132.76 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 417.601% |
| Alkermes plc | -166.73 Million USD | 206.553% |
| Agenus Inc. | 274.13 Million USD | 35.191% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 90.499% |
| Aptorum Group Limited | 1.35 Million USD | -12992.113% |
| Ardelyx, Inc. | 34.51 Million USD | -414.795% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -4051.075% |
| Bicycle Therapeutics plc | -481.46 Million USD | 136.901% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -391.292% |
| ChromaDex Corporation | -24.04 Million USD | 838.797% |
| Chimerix, Inc. | -25.51 Million USD | 796.265% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -2449.714% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 850.374% |
| CRISPR Therapeutics AG | -150.84 Million USD | 217.781% |
| Precision BioSciences, Inc. | -85.41 Million USD | 308.015% |
| Dyadic International, Inc. | -6.37 Million USD | 2885.564% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 1215.082% |
| Fortress Biotech, Inc. | 7.66 Million USD | -2217.886% |
| Lantern Pharma Inc. | -21.7 Million USD | 918.614% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 260.73% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 2179.625% |
| Incyte Corporation | -3.17 Billion USD | 105.596% |
| IO Biotech, Inc. | -140.69 Million USD | 226.274% |
| Jaguar Health, Inc. | 29.39 Million USD | -504.491% |
| Novavax, Inc. | -298.29 Million USD | 159.561% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -3228.949% |
| Opthea Limited | 28.15 Million USD | -530.973% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 1158.229% |
| ContextLogic Inc. | -232 Million USD | 176.58% |
| MiMedx Group, Inc. | -33.9 Million USD | 624.073% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -1642.678% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 7767.843% |
| NextCure, Inc. | -6.47 Million USD | 2843.029% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 451.807% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 2885.17% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -1360.677% |
| Vaxcyte, Inc. | -368.22 Million USD | 148.249% |
| PDS Biotechnology Corporation | -32.7 Million USD | 643.173% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -928.279% |
| Pharming Group N.V. | 109.8 Million USD | -61.803% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 1121.304% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 201.39% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 1059.327% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 1059.327% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 2602.338% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 3131.843% |
| Acelyrin, Inc. | -216.9 Million USD | 181.91% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 3266.801% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 10405.452% |
| Summit Therapeutics Inc. | 34.67 Million USD | -412.39% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 2711.583% |
| Senti Biosciences, Inc. | 1.74 Million USD | -10110.69% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 196.24% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 329.391% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 3030.815% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -177977.359% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -28190.764% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 251.792% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 205.607% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -60.247% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 2438.942% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 237.604% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -2476.887% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 173.306% |
| Immix Biopharma, Inc. | -17.5 Million USD | 1114.667% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 156.099% |
| MEI Pharma, Inc. | -3.7 Million USD | 4895.304% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -1320.078% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -9.845% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -539.247% |
| Fortress Biotech, Inc. | 7.66 Million USD | -2217.886% |
| Precigen, Inc. | -481 Thousand USD | 37036.798% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -1161.743% |
| AlloVir, Inc. | -62.69 Million USD | 383.395% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 419.463% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -188.11% |
| ImmuCell Corporation | 10.99 Million USD | -1516.532% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 215.258% |
| Onconetix, Inc. | 5.33 Million USD | -3232.422% |
| PureTech Health plc | -167.19 Million USD | 206.261% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 683.276% |
| Elevation Oncology, Inc. | -19.11 Million USD | 1029.313% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 3719.189% |
| Seer, Inc. | -4.24 Million USD | 4290.236% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 839.135% |
| Innoviva, Inc. | 255.56 Million USD | 30.481% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 418.033% |
| ESSA Pharma Inc. | -33.62 Million USD | 628.428% |
| GlycoMimetics, Inc. | -40.98 Million USD | 533.496% |
| GT Biopharma, Inc. | -1.02 Million USD | 17501.175% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 362.11% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -190.034% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 232.508% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 1382.232% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 715.357% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 235937.736% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 675.679% |
| Aptose Biosciences Inc. | -8.19 Million USD | 2268.018% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 5778.011% |
| Soligenix, Inc. | -4.95 Million USD | 3688.055% |
| Century Therapeutics, Inc. | 847 Thousand USD | -20875.915% |
| Kura Oncology, Inc. | -20.11 Million USD | 983.12% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 534.115% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 2215.575% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -9652.785% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 5657.272% |
| Autolus Therapeutics plc | -186.59 Million USD | 195.213% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 460.348% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 164.42% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -418.46% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -8.09% |
| GRI Bio, Inc. | -1.79 Million USD | 10003.344% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 2077.792% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 634.221% |
| IGM Biosciences, Inc. | -72.6 Million USD | 344.699% |
| INmune Bio, Inc. | -25.41 Million USD | 799.17% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -17.698% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 450.71% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 1193.371% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 6258.425% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -367.358% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 531.385% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -457.209% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 52.992% |
| Verastem, Inc. | -37.27 Million USD | 576.597% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 2058.184% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 442.575% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 1273.875% |
| Histogen Inc. | -7.48 Million USD | 2472.993% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 922.268% |
| Surrozen, Inc. | -32.66 Million USD | 643.92% |
| Organovo Holdings, Inc. | -1.5 Million USD | 11889.383% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 4326.633% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -837.047% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -6691.514% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -4174.928% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 2219.828% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 508.973% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 1318.822% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 156.083% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 24705.434% |
| Apollomics, Inc. | -27.39 Million USD | 748.534% |
| Amarin Corporation plc | -191.04 Million USD | 192.999% |
| Mesoblast Limited | 55.96 Million USD | -217.47% |
| Turnstone Biologics Corp. | -14.58 Million USD | 1318.225% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 802.459% |
| Synaptogenix, Inc. | -28.66 Million USD | 719.877% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 19081.41% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -264.578% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 20708.777% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 2545.142% |
| Exelixis, Inc. | -73.05 Million USD | 343.211% |
| Better Therapeutics, Inc. | -860 Thousand USD | 20758.837% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 839.874% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 173.607% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -24037.238% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 2488.583% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -14067.943% |
| Gritstone bio, Inc. | 39.49 Million USD | -349.901% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 311.253% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 6849.869% |
| Avid Bioservices, Inc. | 169.72 Million USD | -4.677% |
| Insmed Incorporated | 721.62 Million USD | 75.38% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 2043.508% |
| MediWound Ltd. | -5.32 Million USD | 3438.331% |
| OmniAb, Inc. | 9.2 Million USD | -1830.523% |
| Alector, Inc. | -35.63 Million USD | 598.544% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -106.658% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 3705.235% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -1241.99% |
| Zai Lab Limited | -775 Million USD | 122.925% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 47.83% |
| Aura Biosciences, Inc. | -21.52 Million USD | 925.394% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 315.405% |
| Immunic, Inc. | -45.34 Million USD | 491.853% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 191.952% |
| Veracyte, Inc. | -203.82 Million USD | 187.166% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 72.165% |
| FibroGen, Inc. | 56.76 Million USD | -212.974% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -1895.126% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 6384.43% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 8681.456% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 96.13% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 5417.749% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 207.051% |
| TG Therapeutics, Inc. | 17.86 Million USD | -894.659% |
| Galecto, Inc. | -21.21 Million USD | 937.415% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 846.967% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 88.679% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 825.997% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 1643.982% |
| XBiotech Inc. | -200.02 Million USD | 188.823% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 311.253% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -3823.719% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 603.831% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 330.084% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -3021.877% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 204.255% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 292.333% |
| Vaxxinity, Inc. | 10.13 Million USD | -1653.514% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 75.869% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 1750.013% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 369.37% |
| NexImmune, Inc. | -3.13 Million USD | 5769.631% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 5245.752% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 1275.705% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 755.594% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 2079.333% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 142717.7% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 537.903% |
| Ainos, Inc. | 4.07 Million USD | -4256.771% |
| Pluri Inc. | 22.82 Million USD | -678.247% |
| Prothena Corporation plc | -608.34 Million USD | 129.205% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 249.606% |
| Celularity Inc. | 65.19 Million USD | -172.536% |
| Rallybio Corporation | -24.1 Million USD | 837.142% |
| Cue Biopharma, Inc. | -33.81 Million USD | 625.344% |
| MeiraGTx Holdings plc | -40.3 Million USD | 540.837% |
| Omeros Corporation | 331.17 Million USD | 46.353% |
| Humacyte, Inc. | -22.48 Million USD | 890.118% |
| Immunocore Holdings plc | -358.59 Million USD | 149.545% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 822.954% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 674.952% |
| Blueprint Medicines Corporation | 702.83 Million USD | 74.722% |
| CalciMedica, Inc. | -5.53 Million USD | 3312.767% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 194.393% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 1839.436% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 543.755% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 634.286% |
| Pulmatrix, Inc. | -10.41 Million USD | 1805.539% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 3072.495% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 565.801% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 259.482% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 396.387% |
| Cytokinetics, Incorporated | 642.37 Million USD | 72.342% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 3151.108% |
| Nutriband Inc. | -251.65 Thousand USD | 70698.473% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 620.725% |
| Vor Biopharma Inc. | 4.3 Million USD | -4031.767% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 102.943% |
| Evogene Ltd. | -19.63 Million USD | 1004.889% |
| ProKidney Corp. | -56.23 Million USD | 415.929% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 465.027% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 2023.378% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 86.974% |
| CorMedix Inc. | -43.05 Million USD | 512.673% |
| BioLineRx Ltd. | 7.33 Million USD | -2321.838% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 746.881% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -285.0% |
| Atai Life Sciences N.V. | -28.55 Million USD | 722.123% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -7865.196% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 878.69% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -901.782% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 336.655% |
| MediciNova, Inc. | -50.78 Million USD | 449.85% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 325.45% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 789902.178% |
| GeoVax Labs, Inc. | -6.45 Million USD | 2853.406% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 188.913% |
| Biomea Fusion, Inc. | -166.57 Million USD | 206.661% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 199.269% |
| Mereo BioPharma Group plc | -51.46 Million USD | 445.19% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 287.324% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 160.48% |
| Absci Corporation | -72.59 Million USD | 344.726% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -3791.064% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 175.784% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 288.583% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 285.657% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 554.703% |
| Allakos Inc. | -24.97 Million USD | 811.375% |
| Imunon, Inc. | -4.21 Million USD | 4316.237% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 1305.169% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 231.216% |
| BioAtla, Inc. | -109.01 Million USD | 262.98% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -24037.238% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 19020.767% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -1384.757% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 937.929% |
| XOMA Corporation | -29 Million USD | 712.641% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 1172.862% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 2070.563% |
| aTyr Pharma, Inc. | -7.44 Million USD | 2485.099% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 242.548% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 185.349% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 317.251% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 291.527% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 20778.458% |
| Akari Therapeutics, Plc | -3.84 Million USD | 4720.702% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -10847.507% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 87.134% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 15053.351% |
| UroGen Pharma Ltd. | 4.39 Million USD | -3946.14% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -56.56% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -246788.636% |
| Orgenesis Inc. | 21.78 Million USD | -715.58% |
| Entera Bio Ltd. | -10.62 Million USD | 1771.521% |
| GH Research PLC | -78.07 Million USD | 327.552% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 897.137% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 766.439% |
| Xencor, Inc. | 29.64 Million USD | -499.332% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 9119.439% |
| Replimune Group, Inc. | 1.41 Million USD | -12482.578% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 72643.976% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 240.54% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 15053.351% |
| Portage Biotech Inc. | -4.98 Million USD | 3666.874% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 789902.178% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 368.694% |
| OncoCyte Corporation | -6.56 Million USD | 2807.085% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -19697.574% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 3999.911% |
| Purple Biotech Ltd. | -14.13 Million USD | 1356.656% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 847.878% |
| scPharmaceuticals Inc. | -6.54 Million USD | 2814.53% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 1164.368% |
| HilleVax, Inc. | -165.48 Million USD | 207.361% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 7100.236% |
| Tharimmune, Inc. | -10.93 Million USD | 1724.694% |
| Genprex, Inc. | -6.73 Million USD | 2736.922% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 148.173% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 300.843% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 12781.37% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 5456.313% |
| OKYO Pharma Limited | -826.84 Thousand USD | 21587.142% |
| Savara Inc. | 153 Thousand USD | -116021.569% |
| Curis, Inc. | -23.88 Million USD | 843.777% |
| Daré Bioscience, Inc. | -5.15 Million USD | 3544.534% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 22994.749% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 2961.888% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -14892.911% |
| BeiGene, Ltd. | -2.25 Billion USD | 107.885% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -1339.932% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 129.212% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 195.732% |
| Erasca, Inc. | -37.21 Million USD | 577.391% |
| bluebird bio, Inc. | 108.57 Million USD | -63.64% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 13895.09% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 53.091% |
| DBV Technologies S.A. | -126.98 Million USD | 239.91% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 13895.09% |
| Moderna, Inc. | -2.9 Billion USD | 106.112% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 1816.248% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 1734.763% |
| Molecular Templates, Inc. | 707 Thousand USD | -25029.562% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 666.338% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 48.742% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 316.502% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 293.684% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 650.527% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 616.832% |
| MacroGenics, Inc. | -66.98 Million USD | 365.233% |
| RenovoRx, Inc. | -1.17 Million USD | 15246.292% |
| Adicet Bio, Inc. | -138.78 Million USD | 228.013% |
| Prime Medicine, Inc. | -27.94 Million USD | 735.861% |
| Aditxt, Inc. | 18.12 Million USD | -880.449% |
| Adagene Inc. | -87.62 Million USD | 302.752% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 4365.252% |
| Quantum-Si incorporated | -118.55 Million USD | 249.857% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -393.448% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 2477.061% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 466.254% |
| SciSparc Ltd. | -2.06 Million USD | 8703.68% |
| Vericel Corporation | 1.27 Million USD | -13812.764% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 1581.575% |
| Minerva Neurosciences, Inc. | 41 Million USD | -333.287% |
| Generation Bio Co. | 31.44 Million USD | -464.952% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 201.313% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 674.543% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -52.381% |
| Invivyd, Inc. | -198.47 Million USD | 189.515% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 296.816% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 7509.887% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 350.976% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 2703.165% |
| 2seventy bio, Inc. | 181.71 Million USD | 2.228% |
| ADMA Biologics, Inc. | 90.06 Million USD | -97.262% |
| Clene Inc. | 3.34 Million USD | -5219.341% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 2056.092% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 925.931% |
| GeoVax Labs, Inc. | -6.45 Million USD | 2853.406% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 151.628% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 783.339% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 4442.248% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -3451.899% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 3510.751% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 236.347% |
| Evaxion Biotech A/S | 5.28 Million USD | -3260.53% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 257.83% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 235.341% |
| Trevena, Inc. | 2.25 Million USD | -7768.291% |
| Surrozen, Inc. | -32.66 Million USD | 643.92% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 444.916% |
| Cingulate Inc. | 3.08 Million USD | -5663.356% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 6149.234% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -2372.047% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 2012.191% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 323.978% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 235.157% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 268.337% |
| Clearmind Medicine Inc. | -3.94 Million USD | 4606.273% |
| Kronos Bio, Inc. | -36.05 Million USD | 592.778% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -1788.256% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -12084.535% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 427.459% |
| Statera Biopharma, Inc. | 14.41 Million USD | -1132.388% |
| ImmunityBio, Inc. | 618.22 Million USD | 71.262% |
| Korro Bio, Inc. | -132.94 Million USD | 233.641% |
| Kineta, Inc. | -4.54 Million USD | 4012.486% |
| BioVie Inc. | -17.73 Million USD | 1101.931% |
| Codexis, Inc. | -43.27 Million USD | 510.589% |
| Celularity Inc. | 65.19 Million USD | -172.536% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 5706.374% |
| Celcuity Inc. | 6.78 Million USD | -2519.087% |
| Virax Biolabs Group Limited | -3.36 Million USD | 5379.91% |
| Cibus, Inc. | -8.07 Million USD | 2299.381% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 4301.135% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -3787.659% |
| IN8bio, Inc. | -16.38 Million USD | 1184.056% |
| Kodiak Sciences Inc. | -103.87 Million USD | 271.038% |
| Annexon, Inc. | -193.75 Million USD | 191.696% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -493416.667% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 1115.292% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 5157.387% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 83.148% |
| Eyenovia, Inc. | 1.25 Million USD | -14015.017% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -560.346% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 5578.446% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 634.382% |
| Arcellx, Inc. | -296.95 Million USD | 159.829% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 1010.827% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 401.768% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 957.172% |
| Moolec Science SA | 117.61 Thousand USD | -150955.979% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 562.684% |
| Geron Corporation | 14.76 Million USD | -1103.618% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 568.553% |
| Royalty Pharma plc | 5.65 Billion USD | 96.86% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 225.629% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 2641.926% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 3412.897% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 226.245% |
| Humacyte, Inc. | -22.48 Million USD | 890.118% |
| Structure Therapeutics Inc. | -124.33 Million USD | 242.888% |
| 89bio, Inc. | -289.05 Million USD | 161.465% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 803.851% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 10064.442% |
| Genelux Corporation | -6.89 Million USD | 2675.243% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 672.027% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -112.522% |
| Notable Labs, Ltd. | -9.77 Million USD | 1917.369% |
| Liquidia Corporation | -80.17 Million USD | 321.595% |
| Mustang Bio, Inc. | -3.73 Million USD | 4855.514% |
| Immunovant, Inc. | -635.22 Million USD | 127.969% |
| Quantum-Si incorporated | -118.55 Million USD | 249.857% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 1111.535% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 4388.342% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -2113.355% |
| Acasti Pharma Inc. | -23 Million USD | 872.293% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 5376.327% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 1193.371% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 228.986% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 5801.071% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 899.145% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 1056.788% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 204.955% |
| PepGen Inc. | -60.67 Million USD | 392.84% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 873.268% |
| United Therapeutics Corporation | -507.7 Million USD | 134.994% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 1028.924% |
| Solid Biosciences Inc. | -47.75 Million USD | 472.075% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 20708.777% |
| Immuneering Corporation | -54.94 Million USD | 423.365% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 4326.633% |
| Silo Pharma, Inc. | -3.52 Million USD | 5141.16% |
| Belite Bio, Inc | -87.27 Million USD | 303.58% |
| XOMA Corporation | -29 Million USD | 712.641% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 351.306% |
| Bionomics Limited | 227 Million USD | 21.736% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 252.789% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 7114.054% |
| uniQure N.V. | -102.95 Million USD | 272.573% |
| Cassava Sciences, Inc. | -121.13 Million USD | 246.667% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 4365.252% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -333.85% |
| Forte Biosciences, Inc. | -11.96 Million USD | 1585.377% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 5841.904% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -167509.434% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 5578.446% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -1895.126% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 2495.712% |
| Altimmune, Inc. | -134.48 Million USD | 232.106% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 10.299% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 7114.054% |
| Compugen Ltd. | -12.9 Million USD | 1476.829% |
| Peak Bio, Inc. | 10.34 Million USD | -1618.214% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 62879.505% |
| Benitec Biopharma Inc. | -50.58 Million USD | 451.244% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 270.279% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -804.383% |
| Zura Bio Limited | -99.8 Million USD | 278.011% |
| PolyPid Ltd. | 6.17 Million USD | -2779.514% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -139.7% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -804.383% |
| Instil Bio, Inc. | 75.35 Million USD | -135.763% |
| argenx SE | -2.02 Billion USD | 108.757% |
| Immunome, Inc. | -97.02 Million USD | 283.106% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 889.802% |
| Verona Pharma plc | -220.44 Million USD | 180.595% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 347.642% |
| Shattuck Labs, Inc. | -121.42 Million USD | 246.319% |
| CervoMed Inc. | -7.79 Million USD | 2379.86% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 195.777% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 4162.794% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 234.861% |
| Moolec Science SA | 117.61 Thousand USD | -150955.979% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 7865.2% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -1017.51% |
| AnaptysBio, Inc. | -18.15 Million USD | 1078.822% |
| Design Therapeutics, Inc. | -18.15 Million USD | 1078.876% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 352.435% |
| NeurAxis, Inc. | 145.7 Thousand USD | -121839.602% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -1481.784% |
| Lumos Pharma, Inc. | -28.49 Million USD | 723.543% |
| Achilles Therapeutics plc | -126.92 Million USD | 239.978% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 347.642% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 27194.383% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 955.24% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -12084.535% |
| Nutriband Inc. | -251.65 Thousand USD | 70698.473% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 1448.918% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 2487.984% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 47.776% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -648.54% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 139.704% |
| Palisade Bio, Inc. | -12.06 Million USD | 1572.818% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 226.623% |
| Beam Therapeutics Inc. | -262.72 Million USD | 167.625% |
| Neurogene Inc. | -131.95 Million USD | 234.641% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -714.384% |
| AEON Biopharma, Inc. | -4.88 Million USD | 3740.697% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 147.102% |
| Sesen Bio, Inc. | -112.55 Million USD | 257.851% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 277.915% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 7667.362% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 555.25% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 313.331% |
| Athira Pharma, Inc. | -88.99 Million USD | 299.627% |
| Vaccinex, Inc. | -1.28 Million USD | 13893.944% |
| HCW Biologics Inc. | 2.85 Million USD | -6119.326% |
| XOMA Corporation | -29 Million USD | 712.641% |
| Nektar Therapeutics | 210.24 Million USD | 15.494% |
| Arvinas, Inc. | -313.8 Million USD | 156.618% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -10847.507% |
| Merus N.V. | -192.88 Million USD | 192.11% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -196.184% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 2660.767% |
| Rezolute, Inc. | -68.16 Million USD | 360.63% |
| Clene Inc. | 3.34 Million USD | -5219.341% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 1447.281% |
| BeyondSpring Inc. | -13.75 Million USD | 1391.647% |
| Synlogic, Inc. | -6.68 Million USD | 2757.681% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -15567.196% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 2201.313% |
| Peak Bio, Inc. | 10.34 Million USD | -1618.214% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 315.562% |
| Krystal Biotech, Inc. | -350.23 Million USD | 150.728% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -43.135% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 205.13% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 5727.428% |
| MannKind Corporation | 143.89 Million USD | -23.466% |
| Ikena Oncology, Inc. | -109.15 Million USD | 262.763% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 2446.665% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 636.755% |
| Gossamer Bio, Inc. | 180.35 Million USD | 1.491% |
| CohBar, Inc. | -5.93 Million USD | 3095.685% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 697.237% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -3791.064% |
| Legend Biotech Corporation | -949.39 Million USD | 118.714% |
| Mural Oncology plc | -255.84 Million USD | 169.443% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -451.501% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 3871.588% |
| Disc Medicine, Inc. | -358.28 Million USD | 149.588% |
| Champions Oncology, Inc. | 4.81 Million USD | -3592.145% |
| REGENXBIO Inc. | 54.76 Million USD | -224.397% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 66169.682% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 217.641% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 2071.437% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 320.203% |
| Vaxart, Inc. | -8.24 Million USD | 2255.879% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 454.058% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 239.712% |
| Cellectis S.A. | -43.85 Million USD | 505.121% |
| Longeveron Inc. | -2.9 Million USD | 6209.56% |
| Repare Therapeutics Inc. | -107.85 Million USD | 264.722% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 81.653% |
| Inozyme Pharma, Inc. | 12 Million USD | -1380.057% |
| Revolution Medicines, Inc. | -608.2 Million USD | 129.212% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 14544.39% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 167.014% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 218.387% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 1235.464% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 24108.919% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 101.858% |
| Denali Therapeutics Inc. | -74.86 Million USD | 337.315% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 1581.575% |
| Veru Inc. | 4.77 Million USD | -3616.886% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 1679.815% |
| Cingulate Inc. | 3.08 Million USD | -5663.356% |
| Passage Bio, Inc. | 4.58 Million USD | -3774.94% |
| Context Therapeutics Inc. | -14.44 Million USD | 1329.537% |
| Exicure, Inc. | 5.84 Million USD | -2937.545% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 177.12% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 548.992% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -1032.28% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 402.045% |
| Nuvalent, Inc. | -335.38 Million USD | 152.973% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -10144.006% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 338.535% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 2098.493% |
| OmniAb, Inc. | 9.2 Million USD | -1830.523% |
| Anew Medical, Inc. | 1.43 Million USD | -12302.816% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -984.536% |
| Lipocine Inc. | -4.75 Million USD | 3836.724% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 261.767% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -1066.476% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 450.71% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -613.747% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 2743.446% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 369.898% |
| Ocugen, Inc. | -32.52 Million USD | 646.312% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 307.614% |
| Q32 Bio Inc. | -37.94 Million USD | 568.183% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 28390.764% |
| Alumis Inc. Common Stock | -13.52 Million USD | 1413.223% |
| Equillium, Inc. | -22.39 Million USD | 893.435% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 794.876% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 644.541% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 71764.078% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -32.545% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -5455.535% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -53993.734% |
| Dominari Holdings Inc. | 195 Thousand USD | -91010.769% |
| Edesa Biotech, Inc. | -5.26 Million USD | 3473.249% |
| vTv Therapeutics Inc. | -8.91 Million USD | 2092.441% |
| Bio-Techne Corporation | 267.74 Million USD | 33.644% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 1196.095% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 250.445% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 2214.316% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 1504.363% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 172.482% |
| Nkarta, Inc. | 57.29 Million USD | -210.068% |
| BioCardia, Inc. | 212 Thousand USD | -83704.717% |
| Iterum Therapeutics plc | 13.43 Million USD | -1222.116% |